Strainprint™ Closes USD $3 Million (Cdn.$3.8M) Series A Funding
TORONTO, May 8, 2018 /PRNewswire/ – StrainprintTM Technologies — the leader in cannabis data and analytics is pleased to announce the closing of a USD $3 Million (Cdn.$3.8 Million) non-brokered, Series A private placement. The round was led by strategic industry investor, Cesare Fazari, Chairman of Molecular Science Corp and seed investor of leading cannabis companies, Ample Organics and Hydropothecary. Mr. Fazari […]
WSU uses Strainprint Technologies Data in study
PULLMAN, WA – In a first-of-a-kind study, Washington State University scientists examined how peoples’ self-reported levels of stress, anxiety and depression were affected by smoking different strains and quantities of cannabis at home. Their work, published this month in the Journal of Affective Disorders, suggests smoking cannabis can significantly reduce short-term levels of depression, anxiety, […]
Strainprint President & CTO, David Berg Featured in Cannabis Investing News
The legalization of cannabis has allowed researchers to begin investigating the drug at more in-depth levels than before. With the current state of cannabis working towards legalization across the globe, new channels of research are opening up across the board as an effort to rapidly catch up with a market ready to consume a product […]
Strainprint Featured in The Leaf Cannabis News: Finding the right stuff Cannabis-tech firms' experience-based apps help medical and recreational users through the confusing maze of strains and their effects
03/15/2018 – Strainprint was recently featured In The Leaf Cannabis News Where our President, David Berg discussed Cannabis Tech-Apps. – Berg says Strainprint has “over six million data points collected and over 300,000 validated sessions,” describing that database as “the largest longitudinal study on cannabis in the world.” He says that information can address the dearth of […]
Jessica Moran, Director of Marketing & Communications Featured in Blysscloud's "The Five"
February 23, 2018 – Our Director of Marketing & Communications, Jessica Moran was featured in Blysscloud’s “The Five” – THIS WOMAN WANTS YOU TO USE CANNABIS BETTER – THE 5 WITH JESSICA MORAN
Strainprint™ Technologies Ltd. Welcomes 48North Cannabis Co. parent company of ACMPR Licensed Producer Delshen Therapeutics
Strainprint™ – the leader in cannabis data collection and strain efficacy reporting – is excited to announce that 48North Cannabis (48North) has subscribed to Strainprint’s world-leading cannabis data & analytics platform to help guide its operational growth and product development.
Daily Marijuana Observer – Better Know a CTO
Our President and Chief Technology Officer, Dave Berg was recently featured in the The Daily Marijuana Observer – Get to know all about what makes Dave tick, and why he’s so passionate about Strainprint.
Blyss Cloud – Why We Love The Strainprint Marijuana App
Recently, the Strainprint App was featured on Blyss Cloud. Read all about why they love the Strainprint App!
5 Unique Facts About Cannabidiol (CBD)
When talking about cannabis, there are two main cannabinoids that make their way into most cannabis discourses: THC and CBD. While each are of equal value amongst the hundreds of cannabinoid compounds within the cannabis plant, they serve very different functions for the user and achieve different effects.